- Home
- REAL vs VNDA Comparison
REAL vs VNDA Comparison
Compare REAL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- VNDA
- Stock Information
- Founded
- REAL 2011
- VNDA 2002
- Country
- REAL United States
- VNDA United States
- Employees
- REAL N/A
- VNDA N/A
- Industry
- REAL Other Specialty Stores
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- VNDA Health Care
- Exchange
- REAL Nasdaq
- VNDA Nasdaq
- Market Cap
- REAL 641.9M
- VNDA 288.2M
- IPO Year
- REAL 2019
- VNDA 2006
- Fundamental
- Price
- REAL $5.29
- VNDA $4.78
- Analyst Decision
- REAL Buy
- VNDA Strong Buy
- Analyst Count
- REAL 5
- VNDA 3
- Target Price
- REAL $8.40
- VNDA $15.33
- AVG Volume (30 Days)
- REAL 2.7M
- VNDA 421.0K
- Earning Date
- REAL 08-05-2025
- VNDA 07-30-2025
- Dividend Yield
- REAL N/A
- VNDA N/A
- EPS Growth
- REAL N/A
- VNDA N/A
- EPS
- REAL N/A
- VNDA N/A
- Revenue
- REAL $616,717,000.00
- VNDA $201,351,000.00
- Revenue This Year
- REAL $11.70
- VNDA $16.86
- Revenue Next Year
- REAL $10.10
- VNDA $39.78
- P/E Ratio
- REAL N/A
- VNDA N/A
- Revenue Growth
- REAL 11.89
- VNDA 13.37
- 52 Week Low
- REAL $2.24
- VNDA $3.81
- 52 Week High
- REAL $11.38
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- REAL 50.82
- VNDA 53.88
- Support Level
- REAL $5.17
- VNDA $4.85
- Resistance Level
- REAL $5.56
- VNDA $5.12
- Average True Range (ATR)
- REAL 0.26
- VNDA 0.18
- MACD
- REAL 0.06
- VNDA 0.01
- Stochastic Oscillator
- REAL 69.01
- VNDA 54.05
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.